Origen de la red de primer grado Rosalie Cull.
Entidad | Tipo de entidad | Industria | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 7 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Rosalie Cull a través de su red personal
Empresa | Sector | Personas relacionadas | Puesto principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Orchestra Therapeutics, Inc.
Orchestra Therapeutics, Inc. Financial ConglomeratesFinance Orchestra Therapeutics, Inc. operates as a development stage company. It previously operated as an immuno-pharmaceutical company focused on developing products to treat autoimmune diseases. The company was founded in 1986 and is headquartered in Carlsbad, CA. | Financial Conglomerates | Director/Board Member | |
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Biotechnology | Director/Board Member | |
Hamilton Pharmaceuticals, Inc.
Hamilton Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Hamilton Pharmaceuticals, Inc. develops and supplies pharmaceuticals. It also develops and commercializes novel medical treatments for central nervous system disease. The company was founded in April 2004 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
NEUREN PHARMACEUTICALS LIMITED | Pharmaceuticals: Generic | Corporate Officer/Principal Chairman | |
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Pharmaceuticals: Major | Chairman | |
QRXPHARMA LTD. | Pharmaceuticals: Major | Director/Board Member | |
Pinnacle Biologics, Inc.
Pinnacle Biologics, Inc. Medical/Nursing ServicesHealth Services Pinnacle Biologics, Inc. specializes in revitalizing healthcare therapies by developing approaches to the global commercialization of products. It engages in assisting pharmaceutical and biotech companies in providing full portfolio of services aimed at the commercialization or continuation. The company was founded by Viren Grover, Guillermo A. Herrera and James R. Miller in 2007 and is headquartered in Chicago, IL. | Medical/Nursing Services | Director/Board Member | |
University of Melbourne
University of Melbourne Other Consumer ServicesConsumer Services The University of Melbourne, founded in 1853, is a world-renowned institution located in Parkville, Australia. The university is a leader in education, teaching, and research, offering a wide range of coursework and research programs. | College/University | Doctorate Degree | |
Kidd & Co. LLC
Kidd & Co. LLC Investment ManagersFinance Kidd & Co. LLC (Kidd) is a private equity firm founded in 1976 by William J. Kidd. The firm is headquartered in Old Greenwich, Connecticut. | Investment Managers | Private Equity Investor | |
Kidder Peabody & Co., Inc. /Non Retail Unit/
Kidder Peabody & Co., Inc. /Non Retail Unit/ Investment Banks/BrokersFinance Part of UBS Group AG, Kidder Peabody & Co., Inc. /Non Retail Unit/ is a security brokers & dealers. The company is based in Staten Island, NY. | Investment Banks/Brokers | Corporate Officer/Principal | |
University of Leeds | College/University | Doctorate Degree | |
BTC HEALTH LIMITED | Investment Managers | Chairman | |
Monash University
Monash University Other Consumer ServicesConsumer Services Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia. | College/University | Doctorate Degree | |
University of Akron
University of Akron Other Consumer ServicesConsumer Services University of Akron provides public research education. Its programs include under graduate studies, graduate studies, international studies, law, and continuing education. The company was founded in 1870 and is headquartered in Akron, OH. | College/University | Undergraduate Degree | |
University of Illinois | College/University | Doctorate Degree | |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Mayne Pharma Ltd. manufactures pharmaceutical products. It distributes generic injectables for the oncology market. The company's competitors include Sandoz, Bedford Labs, and Ebewe. It was founded in November 2005 and is headquartered in Melbourne, Australia. | Pharmaceuticals: Other | Corporate Officer/Principal | |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Australian Institute of Co. Directors is a non-profit organization that provides leadership on director issues. It offers governance education, director development, and advocacy. The organization was founded in January 1, 1990 and is headquartered in Sydney, Australia. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
African Wildlife Foundation, Inc.
African Wildlife Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Illinois Ventures LLC
Illinois Ventures LLC Investment ManagersFinance Illinois Ventures LLC (Illinois Ventures) is a venture capital firm founded in 2000. The firm is headquartered in Champaign, Illinois. | Investment Managers | Chairman | |
Opes Prime Group Ltd.
Opes Prime Group Ltd. Investment Banks/BrokersFinance Opes Prime Group Ltd. provides securities lending and equity financing services. It offers products to the individual and institutional investors. Opes Prime Group was founded in 2003 by Laurie Emini & Julian Smith and is located in Melbourne, Australia. | Investment Banks/Brokers | Chairman | |
Hatchtech Pty Ltd.
Hatchtech Pty Ltd. Pharmaceuticals: MajorHealth Technology Hatchtech Pty Ltd. operates as pharmaceutical product company. It offers Xeglyze lotion that is head lice treatment. The company was founded by Vernon Morrison Bowles in 2001 and is headquartered in in Melbourne, Australia. | Pharmaceuticals: Major | Director/Board Member | |
BTC Health
BTC Health Investment ManagersFinance BTC Speciality Health Pty Ltd (BTC Health) is a private equity firm founded in 2000. The firm is headquartered in Camberwell, Australia. | Investment Managers | Chairman | |
FIREBRICK PHARMA LIMITED | Pharmaceuticals: Major | Director/Board Member | |
Perseis Therapeutics Ltd. | Director/Board Member | ||
Oncolyze, Inc.
Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Director/Board Member |
Estadísticas
Internacional
Estados Unidos | 15 |
Australia | 12 |
Reino Unido | 3 |
Nueva Zelanda | 2 |
Sectorial
Health Technology | 11 |
Finance | 9 |
Consumer Services | 6 |
Commercial Services | 4 |
Health Services | 2 |
Operativa
Director/Board Member | 14 |
Chairman | 6 |
Corporate Officer/Principal | 5 |
Doctorate Degree | 4 |
Chief Tech/Sci/R&D Officer | 4 |
Las relaciones más conectadas
Insiders | |
---|---|
James L. Foght | 13 |
Richard Treagus | 10 |
Igor Gonda | 4 |
Clive Blower | 4 |
Peter Gillooly | 2 |
Tina Soulis | 2 |
Nuno D'Aquino | 1 |
- Bolsa de valores
- Insiders
- Rosalie Cull
- Conexiones Empresas